VTE burden set to hit 1.71 million cases by 2034

It is being driven by the ageing population and improvements in diagnostics.

The global burden of diagnosed incident venous thromboembolism (VTE) cases is projected to reach 1.71 million by 2034, growing at an annual growth rate of 1.41%.

According to a GlobalData report, it is being driven by the ageing population and improvements in diagnostics.

Growth drivers also include rising rates of hip and knee replacement surgeries alongside increasing hospitalisation and immobility amongst older age groups.

VTE comprises deep vein thrombosis and pulmonary embolism, slightly more prevalent in women than men.

By risk group, approximately 14.5 million medically ill discharges amongst those aged 40 and older were at risk of VTE globally in 2024, whilst total hip and knee replacement numbers are expected to rise from 2024 to 2034.

By market, the US is forecast to record 1.08 million diagnosed incident cases by 2034, whilst the five major European markets and Japan are estimated to account for nearly 582,000 and 46,000 cases, respectively.